Alpha Tau Medical Ltd (DRTS) Stock Analysis

Alpha Tau Medical Ltd (DRTS) is a publicly traded company in the HEALTHCARE sector. It trades at $10.58, carries a market capitalization of $841.84M. This page summarizes the public market data, fundamentals, and frequently asked questions for DRTS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Alpha Tau Medical Ltd currently has a Bullish sentiment score of 0.43.

About Alpha Tau Medical Ltd

Alpha Tau Medical Ltd. (Ticker: DRTS) is a pioneering clinical-stage oncology company focused on the innovative development and commercialization of its proprietary alpha-emitting radiation therapy, Alpha DaRT, specifically designed to target solid tumors. Based in Jerusalem, Israel, with operational presence in the United States, the company is poised to transform cancer treatment by delivering a novel therapeutic approach that effectively reduces collateral damage to healthy tissue while en...

GNG Research Analysis

GNG Research scores Alpha Tau Medical Ltd (DRTS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for DRTS.

Frequently Asked Questions

Does DRTS pay dividends?

Alpha Tau Medical Ltd (DRTS) does not currently pay a regular dividend.

What is DRTS's market cap?

Alpha Tau Medical Ltd (DRTS) has a market capitalization of $841.84M with a current stock price of $10.58.